Spencer Knight, PhD
Vice President
New York
Spencer Knight is a Vice President at General Atlantic and focuses on investments in the firm’s Life Sciences Sector. Before joining General Atlantic in 2023, Spencer was a Senior Director and Head of Computational Biology at Kriya Therapeutics. Prior to that, he was a Senior Genomic Data Scientist at Ancestry and a Co-founder at Algen Biotechnologies. Spencer began his career as a Data Scientist at Foresite Capital.
Education
University of California, Berkeley, PhD, Chemistry & Chemical Biology
University of Minnesota, Twin Cities, BS, Chemistry